Krowniq Ltd vs Prism Medico Pharmacy Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Lykis Ltd is ₹ 43.95 as of 23 Oct 15:30 . The P/E Ratio of Lykis Ltd changed from 24.2 on March 2022 to 13 on March 2026 . This represents a CAGR of -11.69% over 5 yearsThe P/E Ratio of Prism Medico & Pharmacy Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Lykis Ltd changed from ₹ 50.96 crore on March 2021 to ₹ 81.88 crore on March 2026 . This represents a CAGR of 8.22% over 6 yearsThe Market Cap of Prism Medico & Pharmacy Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Lykis Ltd for the Jun '26 is ₹ 129.65 crore as compare to the Mar '26 revenue of ₹ 146.79 crore. This represent the decline of -11.68% The revenue of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Lykis Ltd for the Jun '26 is ₹ 6.7 crore as compare to the Mar '26 ebitda of ₹ 5.3 crore. This represent the growth of 26.42% The ebitda of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Lykis Ltd changed from ₹ 0.82 crore to ₹ 3.89 crore over 9 quarters. This represents a CAGR of 99.76% The net profit of Prism Medico & Pharmacy Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Lykis Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Prism Medico & Pharmacy Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Lykis Ltd

Lykis Limited, formerly known Greenline Tea & Exports Limited was incorporated on October 15, 1984.
The name change affected from Greenline Tea & Exports Limited to Lykis Limited on May 17, 2012.
The Company is engaged in business of export of FMCG, Cosmetics and other products.
Prior to this, it was into the business of cultivation and marketing of tea. In 1995-96 the company undertook various expansion and diversification projects by way of increasing the plantation areas and setting up a packaging unit. During 1999-2000, demand for tea suffered a great setback resulting in less realisation coupled with the uncontrolled cost inflation, but inspite of all such deterrant adverse forces the company managed a marginal profit. Thereafter, the Company acquired shares of Lykis Pharma Limited and Jin-X Marketing Pvt Ltd.

About Prism Medico & Pharmacy Ltd

Prism Medico and Pharmacy Limited was originally incorporated under the name of Woolite Mercantile Company Limited on 21st February, 1985.
The name of the Company was changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited dated January 9, 2012.
Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
It also engaged into investments, share trading, and financial activities. Over the past years, the Company was not able to carry out any major operations, resulting it engaged in trading. During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.

FAQs for the comparison of Lykis Ltd and Prism Medico & Pharmacy Ltd

Which company has a larger market capitalization, Lykis Ltd or Prism Medico & Pharmacy Ltd?

Market cap of Lykis Ltd is 85 Cr while Market cap of Prism Medico & Pharmacy Ltd is 42 Cr

What are the key factors driving the stock performance of Lykis Ltd and Prism Medico & Pharmacy Ltd?

The stock performance of Lykis Ltd and Prism Medico & Pharmacy Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lykis Ltd and Prism Medico & Pharmacy Ltd?

As of October 25, 2026, the Lykis Ltd stock price is INR ₹43.95. On the other hand, Prism Medico & Pharmacy Ltd stock price is INR ₹31.52.

How do dividend payouts of Lykis Ltd and Prism Medico & Pharmacy Ltd compare?

To compare the dividend payouts of Lykis Ltd and Prism Medico & Pharmacy Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.